Skip to main content

Advertisement

Table 3 Echocardiographic data in study population at baseline and post marathon (n = 25)

From: The impact of repeated marathon running on cardiovascular function in the aging population

Echo parameters Baseline Post-race Follow-up p-value
 LV parameters (2D TTE) 
LVEDD (mm) 50 ± 3 51 ± 5 50 ± 4 0.93
LVESD (mm) 33 ± 5 34 ± 4 32 ± 5 0.82
LVEDV (ml) 114 ± 12 110 ± 10 112 ± 11 0.72
LVESV (ml) 39 ± 11 38 ± 13 40 ± 11 0.77
IVS (mm) 9 ± 2 9 ± 1 9 ± 2 0.82
PWT (mm) 9 ± 1 8 ± 2 9 ± 2 0.71
LVEF (%) 63 ± 4 62 ± 6 64 ± 3 0.79
LV mass/BSA (g/m2) 102 ± 11 103 ± 15 99 ± 17 0.49
 LA parameters (2D TTE) 
LA diameter (mm) 36 ± 4 37 ± 3 36 ± 5 0.66
LA volume (ml) 42 ± 11 44 ± 13 40 ± 13 0.44
 RA and RV parameters (2D TTE) 
RA volume (ml) 37 ± 12 61 ± 12 31 ± 13 0.01*
RVEDD (mm) 27 ± 3 45 ± 2 32 ± 4 0.02*
RV FAC (%) 48 ± 3 29 ± 6 49 ± 4 0.01*
TAPSE (mm) 2.3 ± 0.4 1.4 ± 0.2 2.1 ± 0.3 0.02*
  1. Data are expressed as mean ± SD. *p < 0.05, after the race vs. baseline.
  2. 2D, 2 dimensional; TTE, transthoracic echocardiography; LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; LVEDV, LV end-diastolic volume; LVESV, LV end-systolic volume; IVS, interventricular septum; PWT, posterior wall thickness; LVEF, LV ejection fraction; BSA, body surface area; LA, left atrium; RA, right atrium; RVEDD, RV end-diastolic diameter; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion.